Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice Melisa Dirchwolf; Sebastián Marciano; Andres E. Ruf; Amit G. Singal; Vanina D'Ercole; Paola Coisson; Alina Zerega; Federico Orozco; Ana Palazzo; Eduardo Fassio; Diego Arufe; Margarita Anders; Claudia D'Amico; Luis Gaite; Marcos Thompson; Daniela Perez; Leila Haddad; Ezequiel Demirdjian; Moira Zunino; Adrián Gadano; María Dolores Murga; Carla Bermudez; Jesica Tomatis; Nadia Grigera; Florencia Antinucci; Manuel Baravalle; Maria Mercedes Rodriguez Gazari; Melina Ferreiro; Manuel Barbero; Andrea Curia; Manuel Demonte; Gisela Gualano;

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab Lorenz Kocheise; Jan Kempski; Yunhe Tang; Lorenz Balcar; Victoria Berger; Miriam Tomczak; Joao Gorgulho; Ramsha Masood; Franziska Giehren; Constantin Schmidt; Jan P. Sutter; Thorben W. Fruendt; Francesca Pagani; Sophie Wulf; Julian Kött; Saskia Domanig; Anastasios Giannou; Tanja Bedke; Jöran Lücke; Tao Zhang; Siwen Zhang; Andres Machicote; Ansgar W. Lohse; Marianna Alunni-Fabbroni; Jens Ricke; Najib Ben Khaled; Matthias Pinter; Bernhard Scheiner; Samuel Huber; Johann von Felden; Ignazio Piseddu; Kornelius Schulze;

Development of machine learning-based personalized predictive models for risk evaluation of hepatocellular carcinoma in hepatitis B virus-related cirrhosis patients with low levels of serum alpha-fetoprotein Yuan Xu; Bei Zhang; Fan Zhou; Ying-ping Yi; Xin-Lei Yang; Xiao Ouyang; Hui Hu;